| SC 13G/A | 2021-02-12 | RTW INVESTMENTS, LP | Adverum Biotechnologies, Inc. | 7,227,364 | 7.4% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | Adverum Biotechnologies, Inc. | 7,042,768 | 7.2% | EDGAR |
| SC 13D/A | 2020-12-23 | Versant Ventures IV, LLC | Adverum Biotechnologies, Inc. | 5,003,892 | 5.1% | EDGAR |
| SC 13D/A | 2020-08-20 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 4,109,867 | 4.2% | EDGAR |
| SC 13G/A | 2020-02-14 | RTW INVESTMENTS, LP | Adverum Biotechnologies, Inc. | 6,386,607 | 9.9% | EDGAR |
| SC 13G | 2020-02-14 | Avoro Capital Advisors LLC | Adverum Biotechnologies, Inc. | 5,250,000 | 8.1% | EDGAR |
| SC 13G | 2020-02-14 | ORBIMED ADVISORS LLC | Adverum Biotechnologies, Inc. | 3,944,090 | 6.1% | EDGAR |
| SC 13G/A | 2020-02-13 | RENAISSANCE TECHNOLOGIES LLC | Adverum Biotechnologies, Inc. | 1,455,848 | 2.2% | EDGAR |
| SC 13G/A | 2020-02-12 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Adverum Biotechnologies, Inc. | 1,000,000 | 1.6% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | Adverum Biotechnologies, Inc. | 4,518,433 | 7.0% | EDGAR |
| SC 13G | 2019-05-30 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Adverum Biotechnologies, Inc. | 3,500,000 | 5.5% | EDGAR |
| SC 13D/A | 2019-05-03 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 3,648,212 | 5.8% | EDGAR |
| SC 13D | 2019-03-21 | Sonic Fund II, L.P. | Adverum Biotechnologies, Inc. | 3,348,212 | 5.3% | EDGAR |
| SC 13G/A | 2019-02-14 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Adverum Biotechnologies, Inc. | 26,030 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-14 | RTW INVESTMENTS, LP | Adverum Biotechnologies, Inc. | 6,256,840 | 10.0% | EDGAR |
| SC 13G/A | 2019-02-13 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Adverum Biotechnologies, Inc. | 3,000,000 | 4.8% | EDGAR |
| SC 13G/A | 2019-02-13 | RENAISSANCE TECHNOLOGIES LLC | Adverum Biotechnologies, Inc. | 3,717,767 | 5.9% | EDGAR |
| SC 13G | 2019-02-08 | BlackRock Inc. | Adverum Biotechnologies, Inc. | 4,443,970 | 7.1% | EDGAR |
| SC 13G | 2018-11-16 | RTW INVESTMENTS, LP | Adverum Biotechnologies, Inc. | 3,841,226 | 6.1% | EDGAR |
| SC 13G/A | 2018-02-14 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Adverum Biotechnologies, Inc. | 2,700,000 | 6.0% | EDGAR |